Treatment of infection in animals
AssigneeMars, Incorporated
InventorsMarie-Louise Baillon, Catriona Julie Giffard
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a non-digestible carbohydrate in the manufacture of a composition for treating or preventing pathogenic bacteria in the large intestine of a pet animal. It also provides a method for the prevention or treatment of a pathogenic bacteria in the large intestine of a pet animal, the method comprising administering to said pet animal a composition which comprises a non-digestible carbohydrate.
Claims18
Use of a non-digestible carbohydrate in the manufacture of a composition for the prevention or treatment of pathogenic bacteria in the large intestine of a pet animal.
Use, as claimed in any one of the preceding claims, wherein the non-digestible carbohydrate is an oligosaccharide.
Use, as claimed in any one of the preceding claims, wherein the oligosaccharide is one of more of fructooligosaccharide, galactooligosaccharide, inulin, lactosucrose, maltooligosaccharide, xylooligosaccharide or raffinose.
Use, as claimed in any one of the preceding claims, wherein the pathogenic bacteria is Campylobacter, pathogenic Escherichia coli or Salmonella.
Use, as claimed in any one of the preceding claims, wherein the pet animal is a dog or a cat.
Use, as claimed in any one of the preceding claims, wherein the composition is a pet food product.
A method for the prevention or treatment of pathogenic bacteria in the large intestine of a pet animal, the method comprising administering to said pet animal a composition which comprises a non-digestible carbohydrate.
Dependencies are inferred from the claim text.